Cite
MLA Citation
Vianney Tricou et al.. “Safety and immunogenicity of a tetravalent dengue vaccine in children aged 2–17 years: a randomised, placebo-controlled, phase 2 trial.” Lancet, vol. 395, no. 10234, 2020, pp. 1434–1443. http://access.bl.uk/ark:/81055/vdc_100104109402.0x00004e